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Resident vascular progenitor cells: An emerging role
for non-terminally differentiated vessel-resident cells
in vascular biology
Jason C. Kovacic, Manfred Boehm ⁎Translational Medicine Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute,
National Institutes of Health, Bethesda, MD 20892, USAReceived 14 April 2008; received in revised form 20 May 2008; accepted 22 May 2008Abstract Throughout development and adult life the vasculature exhibits a remarkably dynamic capacity for growth
and repair. The vasculature also plays a pivotal role in the execution of other diverse biologic processes, such as
the provisioning of early hematopoietic stem cells during embryonic development or the regulation of vascular tone
and blood pressure. Adding to this importance, from an anatomical perspective, the vasculature is clearly
an omnipresent organ, with few areas of the body that it does not penetrate. Given these impressive characteristics,
it is perhaps to be expected that the vasculature should require, or at least be associated with, a ready supply of stem
and progenitor cells. However, somewhat surprisingly, it is only now just beginning to be broadly appreciated
that the vasculature plays host to a range of vessel-resident stem and progenitor cells. The possibility that these
vessel-resident cells are implicated in processes as diverse as tumor vascularization and adaptive vascular remodeling
appears likely, and several exciting avenues for clinical translation are already under investigation. This review explores
the various stem and progenitor cell populations that are resident in the microvasculature, endothelium, and vessel walls
and vessel-resident cells capable of phenotypic transformation.
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3Resident vascular progenitorsIntroduction
The significant recent research efforts directed toward stem
and progenitor cells as they relate to cardiovascular biology
have led to many unexpected discoveries of profound
importance. These have included the description, although
controversial, of both resident cardiac progenitor cells
(Beltrami et al., 2003) and endothelial progenitor cells
(Asahara et al., 1997). As a result, several long-held
paradigms are now being challenged, and clinicians and
basic scientists alike are tantalized by the prospect that
these insights may be directed toward clinical therapeutic
applications (Kovacic et al., 2005).
A surprising new paradigm also to arise from this work,
and the focus of this review, is the possibility that stem or
progenitor cells may reside within the vessel wall (Fig. 1).
Even more striking, it appears likely that several distinct
stem/progenitor populations may reside in this location
during development or adult life. Currently our under-
standing of these mural stem/progenitor populations is
rudimentary, their possible biologic function is unclear, and
the prospect that any of these populations are associated
with a stem cell niche is yet to be rigorously investigated.
Nevertheless, potential biologic roles for vessel-resident
stem/progenitor cells are easily envisaged, such as homeo-
static replacement of aged and apoptotic cells and in the
response to vascular injury.
The core focus of this review is vessel-resident stem/
progenitor cells. Therefore, we have excluded stem/pro-
genitor populations that are considered to reside outside the
vasculature, but which may nevertheless be potent for the
formation of vascular structures. As an example, both
embryonic stem cells and certain cardiac progenitor cells
appear able to give rise to vascular cells (endothelial cells,
smooth muscle cells, etc.). However, as neither embryonic
stem cells nor cardiac progenitor cells appear to reside
within the vessel wall, they are not formally considered in
this review. Interested readers are referred to the following
excellent review articles on these populations: for cardiac
progenitor cells, Anversa et al. (2006) and Wu et al. (2008);
for embryonic stem cells, Murry and Keller (2008).Figure 1 The anatomy of a vessel. (A) Four-color confocal micros
510 UV laser scanning confocal microscope system (Carl Zeiss Gmb
shown in blue, rabbit anti-SM22α (Abcam ab14106, Cambridge, MA,
CA, USA) in white, in conjunction with appropriate anti-rabbit and an
internal and external elastic laminae (shown in green) were not staine
with a 488-nm laser line. (B) Schematic representation of adjacentVasculogenesis and Early Vessel Formation
Vasculogenesis, defined as the de novo formation of a
primitive vascular plexus from mesodermal progenitor cells
(Kovacic et al., 2008), and the subsequent formation of an
embryonic circulation are of critical importance to the
developing embryo. Our knowledge of these developmental
programs is based on a large body of research dating back to
the late 1800s and early 1900s (Sabin, 1917)—a fact that
undoubtedly contributes to the cornerstone position vascu-
logenesis holds in our current-day framework for under-
standing vessel formation.
Vasculogenesis is initiated soon after gastrulation by the
aggregation of mesodermal progenitor cells into small
clusters known as blood islands—the earliest discernable
vascular structures (Sabin, 1917; Gonzalez-Crussi, 1971). In
response to a series of cues, including fibroblast growth
factor and vascular endothelial growth factor (VEGF), the
cells of these blood islands undergo partial lineage commit-
ment such that the outermost cells become endothelial
precursors (termed angioblasts), while the central cells
become hematopoietic precursor cells (Risau and Flamme,
1995). The observation that hematopoietic cells and angio-
blasts arise in close proximity has long fueled speculation
that a bipotent cell (Sabin, 1917), the hemangioblast
(Murray, 1932), is the common blood island progenitor.
Recently, numerous sources have provided strong evidence
to support the existence of such bipotent hemangioblast-like
cells, including clonal in vitro embryonic stem cell data (Choi
et al., 1998) and in vivo research performed in both zebrafish
(Vogeli et al., 2006) and mice (Huber et al., 2004). However,
well-conducted studies have also emerged arguing against
the possibility that individual (clonal) hemangioblast pro-
genitors give rise to all endothelial and hematopoietic cells
within blood islands (Ueno and Weissman, 2006).
Regardless of this controversy, it is established that a
critical player during vasculogenesis is VEGF receptor-2
(VEGFR-2), with homozygous VEGFR-2 knockout mice dying
in utero due to a severe reduction in hematopoietic
progenitors and an absence of intra-and extraembryonic
vessel formation (Shalaby et al., 1995). Correspondingly,copic image of mouse femoral artery acquired using a Zeiss LSM
H, Germany). Staining was with 4′,6-diamidino-2-phenylindole
USA) in red, and rat anti-CD31 (eBioscience 14-0311, San Diego,
ti-rat secondary antibodies (Invitrogen, Carlsbad, CA, USA). The
d, but were imaged using autofluoresence emitted when excited
confocal image identifying vascular anatomic structures/layers.
Figure 2 Histologic analysis of mouse aorta at embryonic day
10.5, with the dotted square delineating the area of higher
magnification shown in the upper-left corner. Arrow indicates
hematopoietic cells on the ventral wall of the dorsal aorta. This
image was originally published in Ghiaur et al. (2008) and is
reproduced with by permission of the publisher; copyright by
The American Society of Hematology.
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development, potentially identifying not only hemangio-
blasts (Choi et al., 1998), but also progenitors with broad
mesodermal potential (Ema et al., 2006), including cells
fated to give rise to cardiomyocyte and smooth muscle cell
lineages (Kattman et al., 2006).
Blood islands soon coalesce and fuse, concurrently laying
down a vascular extracellular matrix and developing a
central lumen. While remaining incompletely understood,
distinct differences appear to exist between vasculogenesis
in the emerging extra-and intraembryonic vascular systems
and the respective roles played by hematopoietic precursors
in each (Risau and Flamme, 1995). In particular, the central
core of primitive hematopoietic precursors appears far more
prominent in the emerging extraembryonic system. On the
other hand, intraembryonic vasculogenesis proceeds with
rudimentary vascular/angioblast strands first forming along
the lateral edges of somites. The dorsal aorta thus emerges
as a continuous cord at the ventrolateral somite edges,
continuing into the head to fuse with the ventral aorta, and
forming the first aortic arch by the six-somite stage (Coffin
and Poole, 1988). The generation of hematopoietic stem
cells (HSCs) is also an integral aspect of this program;
however, unlike the extraembryonic system, intraembryonic
HSCs appear to emanate from a discrete region of the wall of
the dorsal aorta and other major embryonic vessels.
The Vessel Wall during Development—the
Emergence of Hematopoietic Stem Cells
and Mesoangioblasts
As alluded to above, the origins of hematopoietic cells and
HSCs have been shrouded in controversy for decades.
Difficulty characterizing these cells arises because they
appear during a very brief window of time in embryonic
development, with various cell types (primitive erythro-
blasts, erythromyeloid progenitors, bdefinitiveQ HSCs)
appearing in rapid succession. The delineation of the origins
of these cells is further confounded by the fact that they are
actively redistributed to different extra-and intraembryonic
host tissues via the primitive circulation soon after their
emergence. Thus, one of the most controversial aspects of
this field is the contribution made by extraembryonic sites
(placenta, yolk sac) to definitive intraembryonic HSCs with
complete lineage competency, with various publications
attesting that extraembryonic contributions are either
unlikely (Cumano et al., 1996, 2001) or highly probable
(Ghiaur et al., 2008; Lux et al., 2008; Rhodes et al., 2008).
Nevertheless, consensus exists that in mice and humans
the first intraembryonic site to exhibit hematopoietic
activity is the para-aortic splanchnopleura, which comprises
the dorsal aorta and the surrounding splanchnic mesoderm
(8.5–10 days postcoitum in mice) (Godin et al. 1995, 1999).
By days 10−12 postcoitum (mice), the aorta, gonads, and
mesonephros have arisen from within the para-aortic
splanchnopleura, and this structure is then called the AGM
(aorta-gonads-mesonephros). From approximately day 9.5 to
12.5 postcoitum (mice), the ventral domain of the dorsal
aortic floor is a particularly rich source of HSCs, constituting
1 in 12 of all cells in this region (Fig. 2) (Godin et al., 1995,
1999; Taoudi and Medvinsky, 2007). Although the umbilicaland vitelline arteries may also generate HSCs (de Bruijn et
al., 2000), there is evidence to suggest that in mammals a
significant proportion of the initial wave of intraembryonic
HSCs is derived from aortic endothelial cells (de Bruijn et al.,
2002). These bhemogenicQ aortic endothelial cells appear to
undergo a phenotypic switch and establish specialized intra-
aortic HSC-bearing bclustersQ that are in continuity with the
luminal surface of the dorsal aortic floor and which are
marked by Runx1 expression (Jaffredo et al., 1998; North et
al., 2002; Dieterlen-Lievre et al., 2006). Human data,
although limited, also suggest that intraembryonic HSCs
may arise from aortic endothelial cells (Tavian et al. 2005).
However, we note several contradictory reports, including
the suggestion that in zebrafish, aortic endothelial cells may
not directly give rise to definitive HSCs, but rather, HSCs may
emerge from the subaortic mesenchyme (Kissa et al., 2008).
Furthermore, alternative explanations as to the origins of
AGM-derived HSCs in mammals have been proposed. These
include the possibility that HSCs are generated in bsubaortic
patchesQ and then migrate toward the aortic lumen, merely
protruding through (rather than arising from) the endothe-
lium (Bertrand et al., 2005). Strong evidence is also mounting
to suggest that, rather than directly giving rise (de novo) to
HSCs, the ventral domain of the dorsal aortic floor may act to
provide local inductive cues that convert yolk sac-derived
(extraembryonic) hemogenic cells into definitive HSCs
(Samokhvalov et al., 2007; Metcalf, 2008).
Regardless of these controversies, aorta-derived HSCs are
released into the circulation and, at least in mammals,
appear to circulate to other organs such as the fetal liver and
spleen, where hematopoiesis is promptly established (Godin
et al., 1999). These secondary hematopoietic sites rapidly
become the predominant site for HSC residence and
expansion, with aortic HSC generation extinguished by
embryonic day 13 postcoitum (mice) (Godin et al., 1999).
5Resident vascular progenitorsIn turn, HSCs from these secondary hematopoietic sites,
possibly including subsequent waves of HSCs that emerge
separate from those originally from the embryonic aorta
(Emambokus and Frampton, 2003), circulate and establish
definitive hematopoiesis in the bone marrow (BM). These BM
HSC niches, well known to be the sites of adult mammalian
hematopoiesis, have been referred to as bvascularQ and
bperivascularQ niches. However, within the adult BM, HSCs
appear merely to reside in close association with the BM
vasculature (and also the endosteum), rather than being
actually vessel-resident or vessel-derived per se (Kiel et al.,
2005; Sugiyama et al., 2006). Therefore, although these so-
called adult BM HSC vascular niches clearly add to the overall
importance of the vasculature with respect to stem cell
biology, they fall outside the scope of this review and will not
be formally considered.
It is also likely that a second population of stem/
progenitor cells, known as mesoangioblasts, arises during
embryogenesis in parallel with aorta-derived HSCs, but from
the roof and lateral walls of the dorsal aorta (Cossu and
Bianco, 2003). Mesoangioblasts are putative multipotent
progenitors able to give rise to endothelium and that have
been shown to differentiate in vivo into skeletal muscle and
multiple other mesoderm-derived connective tissues (bone,
cartilage, dermis, etc.) (Minasi et al., 2002). While the
possibility that mesoangioblasts and HSCs may arise from a
common ancestor has been raised, this remains speculative
at the current time (Minasi et al., 2002). In culture, freshly
established mesoangioblast clones consistently express
markers of early endothelial lineage commitment: CD34,
VEGFR-2, vascular-endothelial (VE)-cadherin, and stem cell
antigen-1 (Sca-1), while mature endothelial markers are not
expressed (Minasi et al., 2002; Cossu and Bianco, 2003).
Other investigators have also confirmed the existence of
endothelial progenitor cell (EPC)-like CD34+CD31− cells in
the outer stromal layer of the human embryonic aorta
(Alessandri et al., 2001). Of note, unlike HSCs that arise from
the dorsal aortic floor, mesoangioblasts appear devoid of
hematopoietic activity (Cossu and Bianco, 2003).
The developmental role of mesoangioblasts is unclear, as
the bulk of postnatal mesoderm-derived tissues are estab-
lished via other canonical embryonic sources such as somites.
Furthermore, mesoangioblasts may not be bfatedQ to give rise
to skeletal muscle, but may do so only if exposed to a
bmyogenic field,Q such as during muscle development or in
response to specific injuries (Cossu and Biressi, 2005). Recent
indirect evidence suggests that embryonic mesoangioblasts
may give rise to a population of interstitial pericytes that
populate skeletal muscle in adult humans and that are able
to generate skeletal muscle in vitro and in vivo (Dellavalle et
al., 2007). Indeed, mesoangioblasts share several common
features with pericytes (see below), most notably a broad
mesenchymal differentiation potential. However, the spatial
and hierarchical relationships of embryonic mesoangioblasts
and adult pericytes remain to be clearly defined, and it is
also possible that a subset of postnatal skeletal muscle
satellite progenitor cells, which differ from skeletal muscle
pericyte progenitors, may also arise from the dorsal aorta or
other regions of the vascular system (De Angelis et al., 1999).
Taken as a whole, it is clear that embryonic mesoangio-
blasts possess a level of developmental complexity that is yet
to be fully understood. While these and many other questionsrelating to these cells remain to be addressed, both HSCs and
mesoangioblasts serve to highlight what we perceive to be an
early and conserved biological precedent for stem and
progenitor cells to reside within the vasculature.Intimal Endothelial Progenitor Cells
Arguably, the modern era of endothelial research began in
the early 1970s when studies using tritiated thymidine
uptake first documented the ability of endothelial cells to
divide and proliferate (Schwartz and Benditt, 1973). It was
soon appreciated that the daily rate of aortic endothelial
replication in rodents was 13k at birth, but this declined to
only 0.1–0.3k at ~6 months of age. However, the rate of
aortic endothelial cell replication was observed to increase
significantly in response to an appropriate stimulus or injury
(Schwartz and Benditt, 1977). These studies also documen-
ted that replicating endothelial cells were not randomly
distributed, but rather appeared as clusters within the
vasculature that were interpreted to be bgrowth centersQ or
bhigh-turnover regionsQ (Schwartz and Benditt, 1976).
Another milestone in endothelial biology occurred in 1997
when Asahara et al. (1997) first identified circulating EPCs
that could be isolated from adult humans and that contribute
to capillogenesis (capillogenesis being a novel term describ-
ing the universal process of new capillary formation; Kovacic
et al., 2008). However, despite over a decade of further
research, currently the precise nature and origin of EPCs
remain enigmatic. Perhaps because EPCs can be derived from
the blood and BM, and as early reports suggested their
surface antigen expression was somewhat similar to HSCs,
the adult BM has been widely assumed to be the likely
reservoir for EPCs. Incorrectly reinforcing this assumption,
EPC status was erroneously ascribed to colonies of blood-
derived cells (referred to as early outgrowth colonies or CFU-
EC) that are now understood to be closely related to
macrophages/monocytes and/or T cells (Gulati et al.,
2003; Rohde et al., 2007; Yoder et al., 2007). Adding further
to this confusion, while some groups have recently recapi-
tulated the potential HSC origins of EPCs/endothelium
(Bailey et al., 2006; Rota et al., 2007), others have suggested
that HSCs do not give rise to EPCs or to progeny with an
endothelial phenotype (Case et al., 2007; Timmermans et
al., 2007; Yoder et al., 2007). Somewhat unexpectedly,
studies have now also suggested that circulating non-BM-
derived progenitor cells may account for a large proportion
of adult neovascularization (Aicher et al., 2007) and
endothelial repair (Xu et al., 2003). Needless to say, at the
current time the precise origin(s) of circulating EPCs remains
a matter of intense debate (Kovacic et al., 2007).
In the midst of this controversy, an interesting possibility
to emerge is that some circulating EPCs may be derived from
the intimal vascular endothelial layer. This revelation has
arisen from the fact that (vessel-derived) endothelial cells
such as human umbilical vein endothelial cells (HUVECs) and
human aortic endothelial cells (HAECs) can be passaged in
vitro forN40 population doublings—a fact that stands in
contrast to the widely held belief that these are terminally
differentiated, mature endothelial cells. Thus, in a succinct
but important study, Ingram et al. (2005) recently undertook
an in vitro analysis of HUVECs and HAECs and addressed the
Figure 3 Scanning electron micrograph of pericytes covering
the surface of an arterial capillary (from rat). The plump
pericyte nuclear area (N) gives rise to primary processes (1-) of
the pericyte that parallel the long axis of the capillary. These in
turn give rise to secondary processes (2-) encircling the capillary
at right angles to the primary process and branching tertiary
processes (3-) extending from the secondary processes. Arrow-
heads indicate areas of the underlying endothelial cell that are
devoid of pericyte coverage. Reproduced from Shepro and Morel
(1993) by permission of the Federation of American Societies for
Experimental Biology.
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authors used a novel single-cell deposition assay that
discriminates EPCs on the basis of their proliferative and
clonogenic potential. In brief, HUVECs, HAECs, and human
umbilical cord blood-derived EPCs were compared, and it was
found that single cells from these populations were able to
undergo at least one division with a frequency of 52, 53, and
55k, respectively. Single endothelial cells derived from cord
blood EPCs displayed greater capacity to form large colonies
(47k) than HUVECs (28k) and HAECs (27k); however, these
vessel-derived populations clearly exhibited significant
capacity in this regard. Together, these findings suggest
that certain endothelial cells derived from the human aorta
or umbilical vein possess progenitor cell potency that is
comparable to that of cord blood-derived EPCs.
Although yet to be replicated, this study has significant
implications with respect to our understanding of capillogen-
esis and vascular biology. For example, if EPCs reside among
other terminally differentiated and relatively nonprolifera-
tive endothelial cells, we must at least consider the
possibility that an EPC niche exists in the intimal lining of
arteries and/or veins. An intimal EPC niche may be of clinical
importance in various scenarios such as reendothelialization
after vascular stenting. However, whether this niche exists,
and what its characteristics may be, remains speculative at
the current time. Also of importance, the distinctions that
were previously drawn between vasculogenesis and angio-
genesis may now require careful reconsideration. Formerly,
these processes were at least partially distinguished on the
basis that only vasculogenesis was thought to involve
progenitor cell proliferation. The fact that the vessel wall
itself may harbor EPCs now suggests that angiogenesis, like
vasculogenesis, may be a progenitor cell-mediated phenom-
enon (Kovacic et al., 2008).Perivascular Progenitor Cells: Pericytes
Pericytes were first described by Eberth (1871) and Rouget
(1879) over 100 years ago and are ubiquitous subendothelial
cells that reside in vessels ranging in size from the
microvasculature to the aorta (Fig. 3). While their develop-
mental origins are complex and yet to be fully understood, in
formed vessels pericytes are elongated cells embedded
within and sharing a common basement membrane with
overlying endothelial cells. Pericytes and endothelial cells
are intimately connected by tight and gap junctions, and
each pericyte may be in contact with several endothelial
cells via elongated processes wrapping around and along the
blood vessel (Gerhardt and Betsholtz, 2003; Collett and
Canfield, 2005). In larger vessels, pericytes may be observed
not only as subendothelial cells in the inner intimal layer, but
also in the media and adventitia associated with the vasa
vasorum (Andreeva et al., 1998). Arguably, however, the best
characterization of these cells has been in the microvascu-
lature, where pericytes closely encircle endothelial cells,
adding anatomical and functional stability to capillary
networks (Benjamin et al., 1998, 1999). The ratio of
pericytes to endothelial cells varies widely across differing
microvascular beds, from approximately 1:1 in retinal
vessels to 1:10 in the lung and 1:100 in striated muscle
(Shepro and Morel, 1993). However, the pericyte coverage ofany given endothelial cell is typically only partial, with
pericyte-free areas thought to be of importance for
transvascular transport of gases and nutrients (Gerhardt
and Betsholtz, 2003).
Pericytes play an important role during capillogenesis, in
which, under the control of platelet-derived growth factor B,
they invest budding endothelial sprouts and control the
proliferation and differentiation of endothelial cells (Bet-
sholtz et al., 2005). Putative mechanisms whereby pericytes
may modulate these processes include initial patterning of
vascular networks, regulation of EPC/endothelial cell pro-
liferation and differentiation, regulation of capillary size,
and synthesis of extracellular matrix proteins. Studies of
genetic knockout mice have demonstrated that capillaries
and microvessels devoid of pericytes develop a series of
abnormal features, including endothelial hyperplasia, tortu-
osity, abnormal endothelial junctions, and increased leakage
of plasma and erythrocytes (Hellstrom et al., 2001; Betsholtz
et al., 2005; Collett and Canfield, 2005). A further important
feature of pericytes is that they possess smooth muscle cell-
like contractile properties and are implicated in the regula-
tion of microvasculature tone (Shepro and Morel, 1993).
Of relevance to this review, significant evidence also points
to the existence of perivascular stem/progenitor cells and a
potential perivascular stem cell niche. This concept is
arguably traceable to the 1980s, when it was described that
pericytes are able to differentiate into osteoprogenitor cells
and participate in cranial bone formation (Sato and Urist,
1985). Several years later it was noted that pericyte-like cells,
derived from various sites including the retinal microvascu-
lature (Schor et al., 1990) and the medial aortic layer
(Bostrom et al., 1993), were capable of osteoblastic differ-
entiation and were likely responsible for arterial calcification
during the atherosclerotic process (Bostrom et al., 1993).
7Resident vascular progenitorsSubsequent studies have clarified that pericytes express α-
smooth muscle actin and various characteristic marker
proteins or surface antigens, including alkaline phosphatase
(ALP), CD146, and NG2 (Dellavalle et al., 2007; Peault et al.,
2007). In contrast, pericytes do not express myogenic (CD56)
or common endothelial antigens (VE-cadherin, vonWillebrand
factor, or CD31). A precise phenotypic characterization at the
cellular level of what proportion of pericytes are multipotent
progenitors remains to be performed. However, current
evidence suggests that a significant proportion may be
competent for the generation of a wide variety of mesench-
ymal tissues, including skeletal muscle (Dellavalle et al.,
2007; Peault et al., 2007), osteoblasts, cartilage (Doherty et
al., 1998), and adipose tissue (Farrington-Rock et al., 2004).
Recently, numerous lines of evidence have converged to
suggest that several btissue-specificQ populations of oligopo-
tent mesenchymal progenitors are actually pericytes. This
has implications for our understanding of progenitor cell
biology, as it suggests that the notion of tissue-specific
progenitor populations, at least for mesenchymal tissues,
may have been overplayed. Rather, ubiquitous pericytes,
with a pan-organ distribution but perhaps with a predilection
to form the principal cells of their host tissue (adipocytes,
skeletal myocytes, etc.), may be at the core of many of these
btissue-specificQ populations (Andreeva et al., 1998; Peault
et al., 2007). For example, it has been previously demon-
strated that the bstromal vascular fractionQ obtained after
the enzymatic digestion and culture of adipose tissue has a
broad mesenchymal differentiation potential (Zuk et al.,
2002). Recently, independent groups have provided strong
evidence to suggest that adipose-derived pericytes are
the principal progenitors within the bstromal vascular
fractionQ responsible for this mesenchymal differentiation
potency (Traktuev et al., 2008; Zannettino et al., 2008). As
a further example, the sorting of cells from human skeletal
muscle as being ALP+CD56− (Dellavalle et al., 2007) or
CD146+CD34−CD45−CD56− (Peault et al., 2007) has been pro-
posed to identify a population of purified pericytes that are
potent for skeletal muscle regeneration. In follow-on
experiments, the use of pericytes for the generation of
normal skeletal muscle is now under investigation for the
treatment of myopathic disorders such as Duchenne mus-
cular dystrophy (Dellavalle et al., 2007). With respect to
teeth, Shi and Gronthos (2003) have localized and identified
human dental pulp progenitor cells as being pericytes, while
others have shown that dental pulp-derived pericytes are
competent for the generation of odontoblast-like cells
(Alliot-Licht et al., 2005). Finally, Dore-Duffy et al. (2006)
have reported that, at least in vitro, central nervous system
pericytes are able to differentiate into cells characteristic of
neurons and glial cells.
Interestingly, pericytes and BM-derived mesenchymal
stromal cells (MSCs) share several properties, including the
repertoire of mesenchymal tissues they are able to give rise
to and the expression of certain surface antigens, including
STRO-1 (Doherty et al., 1998; Shi and Gronthos, 2003; Alliot-
Licht et al., 2005). Provocatively, studies aimed at identifying
non-BMMSCs have shown that, in fact, MSCs reside in virtually
all postnatal organs and tissues in a subendothelial perivas-
cular location. Furthermore, like pericytes, MSCs frequently
express α-smooth muscle actin (da Silva Meirelles et al.,
2006). Thus, taken as a whole, evidence is accumulating tosuggest a close relationship between MSCs and pericytes.
Conceivably, given that MSCs (and pericytes) isolated from
disparate tissues exhibit subtle variability in differentiation
capability, it is possible that MSCs are ubiquitous perivascular
progenitor cells distributed throughout the body, but with a
degree of lineage allegiance to their host tissue. This
hypothesis would also stand for BM-derived MSCs, of which,
residing within a perivascular niche within postnatal BM (Shi
and Gronthos, 2003), one of their tissue-specific roles is the
support and maintenance of the HSC niche. Consistent with
this, it has been shown that non-BM-derived MSC-like cells
from the artery wall are able to support hematopoietic
colonies (Tintut et al., 2003). However, as mentioned above,
it is possible that pericytes may also be competent for the
generation of nonmesenchymal lineages such as neural cells
(usually considered to be ectoderm-derived). Evidently, our
understanding of these mysterious but omnipresent vessel-
resident progenitor cells is far from complete.Medial and Adventitial Progenitor Cells
Inspired by subtle signals indirectly suggesting the existence
of mural vascular progenitor cells, Hu et al. (2004) are to be
credited with providing the first systematic evaluation of the
possibility that progenitor cells reside in the media or
adventitia of mature vessels. Using immunohistochemical
staining of vessels fromApo-E-deficientmice, they found that
the adventitia of the aortic root harbors large numbers of
cells bearing typical stem/progenitor cell markers, including
Sca-1 (21k), c-kit (9k), and CD34 (15k). Only very rare cells
with these surface antigenic characteristics were identified
in either the media or the intimal vascular layers—an
important negative finding, as Sca-1 is also expressed by
apparently mature (intimal) endothelial cells (van de Rijn et
al., 1989). Turning their attention to the adventitial Sca-
1+fraction, Hu et al. (2004) determined that these cells could
differentiate into smooth muscle cells both in vitro and in
vivo. Thus, adventitial Sca-1+progenitor cells gave rise to the
majority of smooth muscle cells that formed the proliferative
neointimal component in a vein graft transplantation model
in Apo-E knockout mice. Importantly, it was also shown that
adventitial progenitor cells were not derived from circulating
BM cells, but rather, these appeared to be bona fide resident
vascular progenitor cells (Hu et al., 2004).
Grenier et al. (2007) also provided support for the
existence of a vessel-resident Sca-1+progenitor. These
authors described a population of Sca-1+CD31−Lin− cells
that could be purified by the enzymatic digestion of bsmallQ
murine vessels obtained from dermis, adipose tissue, and
skeletal muscle. While these Sca-1+CD31−Lin− progenitor
cells did not display robust in vitro adipogenic, neurogenic,
or myogenic potential, they were able to generate high
numbers of apparently mature endothelial cells. Further,
Sca-1+CD31−Lin− progenitor cells, or their progeny, were able
to form cord-like vascular structures in vitro and partici-
pated in capillogenesis in a rodent ischemic hind-limb model
(Grenier et al., 2007). However, while Hu et al. (2004) (see
above) carefully described that their Sca-1+progenitor cell is
resident within the adventitia, a major limitation of the
Greinier et al. (2007) study is that a precise anatomical
localization of their EPC-like Sca-1+cells was not performed.
Table 1 Summary of vessel-resident stem/progenitor cells and EndMT
Stem/progenitor
cell (or process)
Localization of stem/
progenitor cell
(or process)
Major daughter cells
and/or progeny
arising from
this cell/location
Important features of these
vessel-resident cells
Other comments
Embryonic hemogenic
cells and hematopoietic
stem cells
HSCs, which are released
from the embryonic
aortic wall into the
circulation and which
then circulate and
establish secondary
hematopoiesis in distal
sites (liver, spleen, etc.)
HSCs emanate from the ventral
domain of the dorsal embryonic
aorta and play an important
role in establishing
definitive hematopoiesis
in the embryo
HSCs are generated in embryonic
aorta only for a brief period
during development; the exact
nature of this process is controversial
Embryonic mesoangioblasts Endothelium, skeletal muscle,
and various other
mesoderm-derived tissues
(bone, cartilage, dermis, etc.)
Reside in the roof and lateral
walls of the dorsal embryonic
aorta; devoid of hematopoietic
capacity
Developmental role is unclear—the
bulk of postnatal mesoderm-derived
tissues are established via other
canonical embryonic sources
such as somites
Intimal endothelial
progenitor cells
Endothelial cells Capacity of intimal EPCs to divide
and proliferate is comparable
to that of umbilical cord
blood-derived EPCs
Recognized only recently; biologic
role remains to be determined
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Pericytes Broad mesenchymal
differentiation potential,
often with predilection
to form the principal
cell of their host tissue
(adipose, skeletal muscle, etc.)
Ubiquitous subendothelial cells
that reside in vessels ranging
in size from the microvasculature
to the aorta
Pericytes show contractile ability,
but also significant phenotypic
and functional overlap with MSCs
Medial and adventitial
progenitor cells
Different medial and adventitial
progenitor populations are able
to give rise to endothelial
and/or smooth muscle cells
Several populations described in
both the medial and the
adventitial layers, including SP,
CD34+, and Sca-1+cells
The interrelationships of these
medial and adventitial progenitor
populations are unclear;
significant overlap may
exist, including also with pericytes
Endothelial to mesenchymal
transition
Smooth muscle cells, fibroblasts,
and other mesenchymal cells
Certain endothelial cells exhibit
capacity for phenotypic
modulation to other
mesenchymal cell phenotypes
An important developmental
program; importance in adult
pathologic processes and
malignancy is increasingly
recognized; not considered
a bstem cell phenomenonQ
9
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vascular
progenitors
10 J.C. Kovacic, M. BoehmTherefore, it is possible that these Sca-1+CD31−Lin− cells
were merely peripherally associated with bsmall vessels,Q
rather than being actually resident within the wall. None-
theless, these EPC-like Sca-1+cells seem unlikely to have
been pericytes, as they expressed a broad range of
endothelial antigens and were unable to give rise to the
classic pericyte repertoire of mesenchymal tissues.
In contrast to the findings of Hu et al. (2004), it has now
been described that progenitor cells also reside in the
medial layer of healthy arteries of adult mice (Sainz et al.,
2006). Isolated based on their ability to extrude Hoechst-dye,
these cells were described by Sainz et al. (2006) as so-
called bside populationQ (SP) cells, which also display a
Sca-1+c-kit−/lowLin−CD34−/low profile and represent 6k of all
cells in the media of the adult murine aorta but were not
present within the adventitia. Medial SP cells were unable to
give rise to hematopoietic colonies in vitro, but were com-
petent for the generation of both endothelial and smooth
muscle cell progeny and able to form arborescent vessel-like
structures when cultured on Matrigel (Sainz et al., 2006).
Remarkably, a third population of progenitor cells has
been reported to reside between the medial and the
adventitial layers of a wide range of large and medium-
sized human arteries and veins (Zengin et al., 2006) and the
thoracic aorta (Pasquinelli et al., 2007). In the first of these
studies, using predominantly human internal thoracic artery
samples, Zengin et al. (2006) identified CD34+CD31− cells at
the inner border of the adventitial layer, in close proximity to
the external elastic membrane and lying immediately out-
side the medial smooth muscle layer. Unlike the populations
described by Hu et al. (2004) or Sainz et al. (2006), but
similar to those described by Greinier et al. (2007), these
CD34+CD31− cells were an EPC-like population, providing a
significant endothelial contribution to newly formed capil-
lary-like tubes ex vivo. Although robust lineage-tracking
systems were not used, the ability of these CD34+progenitors
to give rise to smooth muscle cells was thought to be low,
leading the authors to adopt the term bvascular wall-resident
CD34+endothelial precursor cells.Q The existence of
CD34+CD31− cells at the medial-adventitial border zone
was also confirmed in vessels from a wide range of human
organs, including bladder, kidney, heart, brain, lung, and
liver (Zengin et al., 2006). Subsequently, Pasquinelli et al.
(2007) corroborated and extended this work by reporting
that CD34+cells are also resident between the medial and the
adventitial layers in the human thoracic aorta.
In the same publication but with no clear relationship to
the above-mentioned CD34+population, Pasquinelli et al.
(2007) also performed ex vivo culture of digested whole
thoracic aortic segments. This gave rise to cells that
exhibited the surface antigenic characteristics of MSCs
(CD44+CD90+CD105+) and that were able form to capillary-
like structures (Pasquinelli et al., 2007). Others have similarly
described the isolation of progenitor cells with broad
mesenchymal differentiation potential after ex vivo culture
of digested vessel segments (Tintut et al., 2003). While it is
possible that MSC-like populations occupy a specific (and
hitherto undescribed) niche within the vascular wall, to the
casual observer it would perhaps appear more likely that
these investigators had merely isolated and expanded
pericytes that were resident within the vascular wall, perhaps
from the vasa vasorum. This example emphasizes thepossibility, or perhaps the likelihood, that there may be
significant overlap between pericytes and the above-men-
tioned medial and adventitial progenitor populations. More-
over, the apparently contradictory findings of several of these
publications relating to the presence of progenitor cells in the
medial versus the adventitial layers, or their profile of surface
antigen expression, highlight the need for further research to
characterize and delineate these populations properly.Endothelial-to-Mesenchymal Transition
In addition to potentially harboring EPCs, a further fascinat-
ing property of the endothelial intimal layer is endothelial-to-
mesenchymal transition or transformation (EndMT). EndMT is
a specific example of the broader and well-described biologic
process known as epithelial-to-mesenchymal transition or
transformation (EMT) (E.M. Zeisberg et al., 2007a). While
purists might reasonably argue that this is not a stem or
progenitor cell-mediated phenomenon, we believe that
EndMT exhibits sufficient bprogenitor-likeQ features to war-
rant further exploration in the final sections of this review.
During development, as the heart tube begins to loop, a
subset of endothelial cells that form the atrioventricular and
outflow-tract endocardium undergo EndMT. This involves the
loss of intercellular adhesions anddetachment (bdelaminationQ)
of endocardial endothelial cells from neighboring cells,
dramatic changes in cell morphology and cytoskeletal struc-
ture, and degradation of the basal lamina. These transformed
(now mesenchymal) cells migrate into the adjacent cardiac
jelly (an underlying expanded layer of extracellular matrix)
resulting in the formation of the cushion mesenchyme and,
ultimately, the cardiac valves and part of the septa (reviewed in
Mjaatvedt et al., 1999). Endocardial EndMToccurs in response
to regionalized myocardial signals, including the transforming
growth factor (TGF)-β (Brown et al., 1996; Ramsdell and
Markwald, 1997; Nakajima et al., 1998), bone morphogenic
protein (BMP) (Mjaatvedt et al., 1999),Wnt/β-catenin (Liebner
et al., 2004), and Notch (Timmerman et al., 2004) signaling
pathways. This developmental program is likely to be under
strict spatiotemporal control involving the action of several or
all of these pathways in their correct sequence, with clear
evidence that the isolated application of even the predominant
pathway (TGF-β) induces only incomplete transition to a
smooth muscle cell phenotype (Hautmann et al., 1999).
Apart from cardiac valve formation, EndMT/EMT may be
involved in the development of aortic smooth muscle cells
(DeRuiter et al., 1997; Arciniegas et al., 2000), the outer-
most (epicardial) cardiac layer (reviewed in Wessels and
Perez-Pomares, 2004), and certain other organs (Thiery,
2002; Nawshad et al., 2004). EMT has also been implicated in
several pathological states, including oncogenesis and tumor
metastasis (Thiery, 2002; Timmerman et al., 2004) and
chronic fibrosing-type injuries in the liver (M. Zeisberg et al.,
2007b), kidney (Zeisberg et al., 2003), and other organs
(Kalluri and Neilson, 2003). A likely mechanism whereby EMT
may contribute to chronic fibrosis is the formation of
fibroblasts from resident epithelial cells, for example, from
hepatocytes (M. Zeisberg et al., 2007b) or renal epithelia
(Iwano et al., 2002). Similar to EMT during development, in
fibrosing conditions EMT has been predominantly described
as being guided by the TGF-β and BMP signaling pathways
11Resident vascular progenitors(E.M. Zeisberg et al., 2007a; M. Zeisberg et al., 2007b).
However, an important contribution to our molecular under-
standing of this process was the discovery that a fundamental
aspect of tumorigenesis arising from EMT is the repression of
E-cadherin transcription and that the transcription factor
Snail is a bmaster gene,Q which governs E-cadherin down-
regulation (Cano et al., 2000). That E-cadherin repression is
involved in EMT has biologic plausibility, as E-cadherin is
fundamental for cell-cell adhesion, and its loss would
therefore facilitate epithelial delamination. Adding clinical
relevance, an E-cadherin germ-line mutation has been
associated with early-onset high-grade gastric tumors in a
large kindred from New Zealand (Guilford et al., 1998).
Multiple publications have also demonstrated that
endothelial cells, including those derived from the adult,
can be induced to undergo EndMT in vitro (Arciniegas et al.,
1992; Paranya et al., 2001; Frid et al., 2002; Ishisaki et al.,
2003). These studies have included proofs that clonally
derived populations may give rise to both endothelial and
smooth muscle cells, prompting some authors to adopt terms
such as bplasticityQ and btransdifferentiationQ and to suggest
that EndMT may arise from progenitor cells (Paruchuri et al.,
2006). Others have also suggested that inflammatory stimuli
may direct microvascular endothelial cells to transition into
mesenchymal-like cells (Romero et al., 1997) and that
pulmonary arteriolar endothelial cells may transdifferenti-
ate into smooth muscle-like cells under the influence of
myocardin (Zhu et al., 2006).
Of great relevance, albeit as somewhat of a surprising
paradigm shift, endothelial cells were very recently
described as participating in cardiac fibrosis via EndMT.
Using murine models of cardiac fibrosis/heart failure in
association with a Cre-lox genetic system to mark perma-
nently cells that have ever expressed Tie1 (an endothelial
marker), E.M. Zeisberg et al. (2007a) reported that cardiac
fibrosis is associated with the emergence of fibroblasts
derived from endothelial cells. In addition, like during
cardiac valve formation, TGF-β1 was found to induce
cultured endothelial cells to undergo EndMT, whereas BMP-
7 preserved the endothelial phenotype. Of potential clinical
relevance, the systemic administration of recombinant
human BMP-7 significantly inhibited EndMT and the progres-
sion of cardiac fibrosis (E.M. Zeisberg et al., 2007a), a finding
consistent with a previous report that TGF-β-neutralizing
antibody administration prevents myocardial fibrosis (Kuwa-
hara et al., 2002).
While the cells undergoing EndMT obviously exhibit some
progenitor-like features, we reiterate that the consensus
view, at the present time, is that EMT/EndMT falls short of
fulfilling the definition of a progenitor cell phenomenon. In
particular, it has been demonstrated that EndMTcan occur in
the absence of cell division (Paranya et al., 2001; Frid et al.,
2002). Nevertheless, the previously described finding that
EPCs may reside in the intimal endothelial layer raises the
possibility that EPCs may be involved in EndMT. Also, it was
very recently suggested that the process of EMT may result in
the generation of cells with many of the properties of self-
renewing stem cells (Mani et al., 2008). Meticulously
designed studies are now required to delineate fully the
progenitor cell status (or otherwise) of EndMT and, most
importantly, which aspects of this process might be exploited
or manipulated for therapeutic gain.Conclusion
A remarkable biological story is emerging: a surprising
number of stem and progenitor cells reside within the
embryonic, developing, and mature vasculature (Table 1).
Further to this, certain endothelial cells or EPCs may be
capable of a hitherto unappreciated degree of cellular
plasticity in the form of EndMT/EMT. A particularly compel-
ling aspect of many of the vascular stem, progenitor, and
other cells discussed in this review is that, as a component of
the vasculature, they have quasi-omnipresence throughout
the body, with a virtual pan-organ distribution. This, along
with the fact that many of the mature cell types that these
vessel-resident progenitor cells are able to give rise to relate
to host tissues (skeletal muscle, adipose tissue, etc.), rather
than the vasculature per se, suggests a significant role(s) in
developmental and adult biology.
With embryonic HSCs as an obvious exception, currently
the true importance of these vessel-resident stem and
progenitor populations is largely unknown. We must be
mindful that several of these vascular stem/progenitor cells
have only just been described and that our overall knowledge
and understanding are limited. Indeed, the possible role of
vessel-resident progenitor cells in the evolution of athero-
sclerotic vascular disease, the No. 1 killer in Western
societies, is poorly understood. Nonetheless, the prospect
that the therapeutic manipulation of vessel-resident stem
and progenitor cells may be used for the treatment of any
number of a broad range of clinical disorders is particularly
exciting. A further understanding of the function and
contribution of resident vascular progenitor cells to devel-
opment, homeostasis, and disease should provide a rational
platform for the successful clinical exploitation of these
cells.
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